首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1509220

配藥藥局市場：依產品類型、依治療領域、依應用、按地區

Compounding Pharmacies Market, By Product Type, By Therapeutic Area, By Application, By Geography

出版日期: 2024年05月29日 | 出版商:

Coherent Market Insights | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024年全球複方製藥市場價值為111.8億美元，預計到2031年將達到169.2億美元，2024年至2031年複合年成長率為6.1%。

圖 1. 2024 年按地區分類的配藥市場佔有率(%)

由於複雜病理的個人化藥物需求不斷成長，預計全球複合製藥市場將在預測期內呈指數級成長。當沒有美國食品藥物管理局(FDA)核准的處方箋藥時，複方藥房會根據患者的特定臨床需求，組合和修改成分來生產定製藥品。這些可以幫助滿足精確的劑量要求或專門的配方，例如針對無法吞嚥固態錠劑的兒童或老年患者的藥物。此外，它還允許藥劑師創造具有獨特口味和給藥途徑的藥物，從而擴大治療選擇。越來越多的老年人被診斷出患有慢性疾病，這推動了對組合藥物的需求。

市場動態：

由於全球需要客製化藥物的慢性病發病率不斷增加，全球複合製藥市場正在穩步成長。此外，不斷增加的老年人口通常需要專門的配方和劑型，這是市場成長的驅動力。複方藥局相對於非處方藥的優勢，如專有劑型、兒科劑型以及滿足患者特定需求的能力，也正在推動市場成長。然而，組合藥物嚴格的法規結構和品質標準可能會阻礙市場成長。昂貴的商業同類產品的可用性也可能阻礙市場成長。新興國家醫療保健支出的增加以及先進複合技術的利用可能為市場成長提供有利可圖的機會。

本研究的主要特點

該報告對全球配藥藥品市場進行了詳細分析，並提供了以 2023 年為基準年的預測期（2024-2031 年）的市場規模（十億美元）和複合年成長率（CAGR%）。
它揭示了各個細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
它根據公司亮點、產品系列、主要亮點、財務業績和策略等參數，對全球製藥市場的主要企業進行了介紹。
主要公司包括 Avella Specialty Pharmacy、Central Admixture Pharmacy Services、Fagron、Fresenius Kabi AG、PharMEDium Services、Institutional Pharmacy Solutions、Cantrell Drug Company、TriangleCompounding Pharmacies、Lorraine's Pharmacy、Rx3, PharmacyPharm、Birin SE ITC 複方藥房和高級藥房。
據信，這份報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球製藥市場迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過分析全球製藥市場時所使用的各種策略矩陣來促進決策。

公司簡介
- Avella Specialty Pharmacy
- Central Admixture Pharmacy Services
- Fagron
- Fresenius Kabi AG
- PharMEDium Services
- Institutional Pharmacy Solutions
- Cantrell Drug Company
- Triangle Compounding Pharmacies
- Lorraine's Pharmacy
- Rx3 Compounding Pharmacy
- B Braun SE
- Clinigen Group PLC
- QuVa Pharma
- ITC Compounding Pharmacy
- Advanced Pharmacy
- Myonex

第10章分析師建議

命運之輪
分析師觀點
Coherent Opportunity Map

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI3199

Global compounding pharmacies market is estimated to be valued at USD 11.18 Bn in 2024 and is expected to reach USD 16.92 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.1% from 2024 to 2031.

Figure 1. Compounding Pharmacies Market Share (%), By Region, 2024

Global compounding pharmacies market is expected to witness growth exponentially over the forecast period, owing to rising demand for personalized medications for complex conditions. Compounding pharmacies combine or alter ingredients into customized formulations as per patient's specific clinical needs when an U.S. Food and Drug Administration approved prescription product is not available. These help to cater accurate dosing requirements and particular formulations like medications for pediatric or geriatric patients who cannot swallow solid pills. Moreover, the ability of compounders to produce medications with unique flavors and routes of administration expands treatment options. Growing geriatric population diagnosed with chronic health conditions boosts demand for compounded medications.

Market Dynamics:

Global compounding pharmacies market is witnessing robust growth due to increasing incidence of chronic medical conditions worldwide requiring customized medications. Moreover, growing geriatric population base that often need specialized formulations and dose forms of drugs can drive the market growth The advantages of compounding pharmacies over commercially available drugs including unique dosage forms, pediatric dose forms, and ability to cater to patient-specific needs can also drive the market growth. However, strict regulatory framework and quality standards for compounded drugs can hamper the market growth. The availability of expensive commercial equivalents can also hamper the market growth. Increasing healthcare expenditure in emerging nations and utilization of advanced technologies in compounding can offer lucrative opportunities for the market growth.

Key Features of the Study:

This report provides an in-depth analysis of the global compounding pharmacies market and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global compounding pharmacies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Avella Specialty Pharmacy, Central Admixture Pharmacy Services, Fagron, Fresenius Kabi AG, PharMEDium Services, Institutional Pharmacy Solutions, Cantrell Drug Company, Triangle Compounding Pharmacies, Lorraine's Pharmacy, Rx3 Compounding Pharmacy, B Braun SE, Clinigen Group PLC, QuVa Pharma, ITC Compounding Pharmacy, Advanced Pharmacy.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global compounding pharmacies market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global compounding pharmacies market.

Detailed Segmentation-

By Product Type:
- Oral
- Capsule
- Tablets
- Mixtures
- Lollipops
- Lozenges
- Topical
- Gels
- Ointments
- Cream
- Lotions
- Rectal
- Nasal
- Ophthalmic
By Therapeutic Area:
- Hormone Replacement Therapy
- Pain Management
- Specialty Drugs
- Nutritional Supplements
- Others
By Application:
- Pediatric
- Adults
- Geriatrics
- Veterinary
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Avella Specialty Pharmacy
- Central Admixture Pharmacy Services
- Fagron
- Fresenius Kabi AG
- PharMEDium Services
- Institutional Pharmacy Solutions
- Cantrell Drug Company
- Triangle Compounding Pharmacies
- Lorraine's Pharmacy
- Rx3 Compounding Pharmacy
- B Braun SE
- Clinigen Group PLC
- QuVa Pharma
- ITC Compounding Pharmacy
- Advanced Pharmacy

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Therapeutic Area
- Market Snapshot, By Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Compounding Pharmacies Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Compounding Pharmacies Market, By Product Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Capsule
Tablets
Mixtures
Lollipops
Lozenges
Topical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Gels
Ointments
Cream
Lotions
Rectal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nasal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ophthalmic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Compounding Pharmacies Market, By Therapeutic Area, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hormone Replacement Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Pain Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Specialty Drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nutritional Supplements
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Compounding Pharmacies Market, By Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Pediatric
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Adults
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Geriatrics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Veterinary
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Compounding Pharmacies Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Avella Specialty Pharmacy
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Central Admixture Pharmacy Services
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Fagron
- Fresenius Kabi AG
- PharMEDium Services
- Institutional Pharmacy Solutions
- Cantrell Drug Company
- Triangle Compounding Pharmacies
- Lorraine's Pharmacy
- Rx3 Compounding Pharmacy
- B Braun SE
- Clinigen Group PLC
- QuVa Pharma
- ITC Compounding Pharmacy
- Advanced Pharmacy
- Myonex